ACE2: the molecular doorway to SARS-CoV-2

被引:0
|
作者
Miriam Marlene Medina-Enríquez
Sandra Lopez-León
José Alberto Carlos-Escalante
Zuleika Aponte-Torres
Angelica Cuapio
Talia Wegman-Ostrosky
机构
[1] Universidad de Barcelona,Facultad de Farmacia
[2] Novartis Pharmaceuticals Corporation,Global Drug Development
[3] Universidad Nacional Autónoma de México,PECEM (MD/PhD), Facultad de Medicina
[4] MS Epidemiology Consultant,Center of Infectious Medicine
[5] Karolinska Institutet,Department of Basic Research
[6] Instituto Nacional de Cancerología,undefined
来源
关键词
ACE2; SARS-CoV-2; COVID-19; Coronavirus;
D O I
暂无
中图分类号
学科分类号
摘要
The angiotensin-converting enzyme 2 (ACE2) is the host functional receptor for the new virus SARS-CoV-2 causing Coronavirus Disease 2019. ACE2 is expressed in 72 different cell types. Some factors that can affect the expression of the ACE2 are: sex, environment, comorbidities, medications (e.g. anti-hypertensives) and its interaction with other genes of the renin-angiotensin system and other pathways. Different factors can affect the risk of infection of SARS-CoV-2 and determine the severity of the symptoms. The ACE2 enzyme is a negative regulator of RAS expressed in various organ systems. It is with immunity, inflammation, increased coagulopathy, and cardiovascular disease. In this review, we describe the genetic and molecular functions of the ACE2 receptor and its relation with the physiological and pathological conditions to better understand how this receptor is involved in the pathogenesis of COVID-19. In addition, it reviews the different comorbidities that interact with SARS-CoV-2 in which also ACE2 plays an important role. It also describes the different factors that interact with the virus that have an influence in the expression and functional activities of the receptor. The goal is to provide the reader with an understanding of the complexity and importance of this receptor.
引用
收藏
相关论文
共 50 条
  • [21] Outsmarting SARS-CoV-2 by empowering a decoy ACE2
    Milena Sokolowska
    Signal Transduction and Targeted Therapy, 5
  • [22] ACE2 glycans preferentially interact with SARS-CoV-2 over SARS-CoV
    Acharya, Atanu
    Lynch, Diane L.
    Pavlova, Anna
    Pang, Yui Tik
    Gumbart, James C.
    CHEMICAL COMMUNICATIONS, 2021, 57 (48) : 5949 - 5952
  • [23] Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein
    Calcagnile, Matteo
    Forgez, Patricia
    Iannelli, Antonio
    Bucci, Cecilia
    Alifano, Marco
    Alifano, Pietro
    BIOCHIMIE, 2021, 180 : 143 - 148
  • [24] Expression pattern and function of SARS-CoV-2 receptor ACE2
    Li Ruiting
    Qin Chengfeng
    生物安全与健康(英文), 2021, 03 (06) : 312 - 318
  • [25] Importance of ACE2 for SARS-CoV-2 Infection of Kidney Cells
    Kroll, Marie-Kristin
    Schloer, Sebastian
    Candan, Peynaz
    Korthals, Nadia
    Wenzel, Christoph
    Ihle, Hannah
    Gilhaus, Kevin
    Liedtke, Kim Rouven
    Schoefbaenker, Michael
    Surmann, Beate
    Schroeter, Rita
    Neugebauer, Ute
    Mall, Gita
    Oswald, Stefan
    Ludwig, Stephan
    Rescher, Ursula
    Vollenbroeker, Beate
    Ciarimboli, Giuliano
    BIOMOLECULES, 2023, 13 (03)
  • [26] Development of ACE2 autoantibodies after SARS-CoV-2 infection
    Arthur, John M.
    Forrest, J. Craig
    Boehme, Karl W.
    Kennedy, Joshua L.
    Owens, Shana
    Herzog, Christian
    Liu, Juan
    Harville, Terry O.
    PLOS ONE, 2021, 16 (09):
  • [27] Blockade of SARS-CoV-2 infection by recombinant soluble ACE2
    Alhenc-Gelas, Francois
    Drueke, Tilman B.
    KIDNEY INTERNATIONAL, 2020, 97 (06) : 1091 - 1093
  • [28] SARS-CoV-2 AND SKELETAL MUSCLE ACE2: EXERCISE CONTRIBUTION
    Fernandes, Tiago
    Oliveira, Edilamar Menezes
    JOURNAL OF APPLIED PHYSIOLOGY, 2020, 129 (04) : 870 - 871
  • [29] SARS-CoV-2 cell entry beyond the ACE2 receptor
    Shamila D. Alipoor
    Mehdi Mirsaeidi
    Molecular Biology Reports, 2022, 49 : 10715 - 10727
  • [30] SARS-CoV-2 cell entry beyond the ACE2 receptor
    Alipoor, Shamila D.
    Mirsaeidi, Mehdi
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (11) : 10715 - 10727